Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL967624 | 0.85 | MLYCD (0.37) | LPAR1LPAR5 | |
| SCHEMBL1768632 | 0.83 | FAAH (0.32) | — | |
| SCHEMBL18274578 | 0.79 | LPAR1 (0.35) | LPAR1LPAR5 | |
| SCHEMBL1758795 | 0.78 | CA12 (0.45) | — | |
| SCHEMBL5618585 | 0.77 | — | — | |
| SCHEMBL20819811 | 0.76 | LIMK1 (0.32) | — | |
| SCHEMBL18274568 | 0.76 | MLYCD (0.42) | LPAR1LPAR5 | |
| SCHEMBL1758831 | 0.75 | FAAH (0.46) | — | |
| SCHEMBL15225307 | 0.75 | FAAH (0.46) | — | |
| SCHEMBL8969981 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240067651-A1 | PRODRUGS OF MYELOPEROXIDASE INHIBITORS | BIOHAVEN THERAPEUTICS LTD. | 2024-02-29 | — | — | US | disclosed |
| EP-2316822-B1 | PREPARATION OF CARBAMATES WITH SOLID CATALYSTS | CONSEJO SUPERIOR INVESTIGACION (ES) | 2016-10-26 | — | — | EP | disclosed |
| US-8735621-B2 | Preparation of carbamates with solid catalysts | CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (ES) | 2014-05-27 | — | — | US | disclosed |
| US-20110124902-A1 | PREPARATION OF CARBAMATES WITH SOLID CATALYSTS | Consejo Superior De Investigaciones Cientificas C/Serrano, 117 (ES) | 2011-05-26 | — | — | US | disclosed |
| EP-2316822-A1 | PREPARATION OF CARBAMATES WITH SOLID CATALYSTS | Consejo Superior De Investigaciones Científicas (ES) | 2011-05-04 | — | — | EP | disclosed |
| US-7247757-B2 | Method of producing a fluorine-containing vinyl ether compound | FUJIFILM CORPORATION (JP) | 2007-07-24 | — | — | US | disclosed |
| US-20060074264-A1 | Method of producing a flourine-containing vinyl ether compound | FUJI PHOTO FILM CO., LTD. | 2006-04-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110124902-A1 | PREPARATION OF CARBAMATES WITH SOLID CATALYSTS | ODC1, RCC1, OTC | LPAR1 3311/4885LPAR5 2711/4885 |
| US-20240067651-A1 | PRODRUGS OF MYELOPEROXIDASE INHIBITORS | MPO, CAT, SOD1 | LPAR1 1597/4885LPAR5 1616/4885 |
| US-20060074264-A1 | Method of producing a flourine-containing vinyl ether compound | AFF1, INF2, AFF2 | LPAR1 2639/4885LPAR5 3293/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.